--Bentley Systems Keeps Quarterly Dividend at $0.06 per Share, Payable Dec. 12 to Shareholders of Record on Dec. 3-January 2024-www.financetom.com

Business

--Bentley Systems Keeps Quarterly Dividend at $0.06 per Share, Payable Dec. 12 to Shareholders of Record on Dec. 3

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Bentley Systems Keeps Quarterly Dividend at $0.06 per Share, Payable Dec. 12 to Shareholders of Record on Dec. 3

Nov 22, 2024 8:06 AM

10:53 AM EST, 11/22/2024 (MT Newswires) --

Price: 48.20, Change: +0.41, Percent Change: +0.87

Previous page： Curbline Properties Q3 Operating FFO, Revenue Rise; Annual Operating FFO Guidance Upgraded Next page： Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Curbline Properties Q3 Operating FFO, Revenue Rise; Annual Operating FFO Guidance Upgraded

Oct 28, 2025

06:44 AM EDT, 10/28/2025 (MT Newswires) -- Curbline Properties ( CURB ) reported Q3 operating funds from operations Tuesday of $0.28 per diluted share, up from $0.19 a year earlier. Four analysts polled by FactSet expected $0.27. Revenue for the quarter ended Sept. 30 was $48.6 million, up from $29.8 million a year earlier. Analysts surveyed by FactSet expected $42.9...

Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact

Oct 28, 2025

Overview * Zebra Q3 net sales rise 5.2% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats analyst expectations, reflecting strong operational performance * Company plans $500 mln share repurchase over next 12 months Outlook * Company expects Q4 sales growth between 8% and 11% * Adjusted EBITDA margin for Q4 expected to be around 22% * Non-GAAP EPS...

Regeneron Pharma's Q3 profit beats on Dupixent strength

Oct 28, 2025

Overview * Regeneron Q3 2025 revenue grows 1% to $3.75 bln, beating analyst expectations * Adjusted EPS for Q3 2025 beats consensus, driven by strong product sales * Company reports strong sales growth for Dupixent and EYLEA HD Outlook * Regeneron updates 2025 R&D expense guidance to $5.68-$5.75 bln * Company revises 2025 SG&A expense guidance to $2.775-$2.845 bln *...

Cruise operator Royal Caribbean beats Q3 adjusted EPS expectations, lifts FY forecast

Oct 28, 2025

Overview * Royal Caribbean Q3 adjusted EPS beats analyst expectations, driven by strong demand and lower costs * Company raises full-year 2025 adjusted EPS guidance to $15.58-$15.63, up 32% yr/yr Outlook * Royal Caribbean raises 2025 Adjusted EPS guidance to $15.58-$15.63 * Company says 2026 bookings have come in at rates well above the prior year * Company expects 2026...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP